KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Asset Utilization Ratio: 2019-2025

Historic Asset Utilization Ratio for Esperion Therapeutics (ESPR) over the last 6 years, with Sep 2025 value amounting to 0.85.

  • Esperion Therapeutics' Asset Utilization Ratio fell 3.63% to 0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.85, marking a year-over-year decrease of 3.63%. This contributed to the annual value of 1.21 for FY2024, which is 135.82% up from last year.
  • Esperion Therapeutics' Asset Utilization Ratio amounted to 0.85 in Q3 2025, which was up 6.93% from 0.80 recorded in Q2 2025.
  • Over the past 5 years, Esperion Therapeutics' Asset Utilization Ratio peaked at 1.01 during Q4 2024, and registered a low of 0.21 during Q2 2022.
  • In the last 3 years, Esperion Therapeutics' Asset Utilization Ratio had a median value of 0.78 in 2025 and averaged 0.69.
  • Examining YoY changes over the last 5 years, Esperion Therapeutics' Asset Utilization Ratio showed a top increase of 2,945.93% in 2021 and a maximum decrease of 73.77% in 2021.
  • Over the past 5 years, Esperion Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.26 in 2021, then climbed by 4.12% to 0.27 in 2022, then surged by 102.37% to 0.54 in 2023, then spiked by 85.43% to 1.01 in 2024, then dropped by 3.63% to 0.85 in 2025.
  • Its Asset Utilization Ratio was 0.85 in Q3 2025, compared to 0.80 in Q2 2025 and 0.78 in Q1 2025.